{"version":"1.0","provider_name":"Farmalider","provider_url":"https:\/\/farmalider.com\/es","author_name":"mjsanz2","author_url":"https:\/\/farmalider.com\/es\/author\/mjsanz2\/","title":"Ideeea Tx announces AGAcell, a cell therapy program for alopecia - Farmalider","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"Nn3ZGBn2CS\"><a href=\"https:\/\/farmalider.com\/es\/news\/ideeea-tx-anuncia-agacell-programa-terapia-celular-alopecia\/\">Ideeea Tx announces AGAcell, a cell therapy program for alopecia<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/farmalider.com\/es\/news\/ideeea-tx-anuncia-agacell-programa-terapia-celular-alopecia\/embed\/#?secret=Nn3ZGBn2CS\" width=\"600\" height=\"338\" title=\"\u00abIdeeea Tx announces AGAcell, a cell therapy program for alopecia\u00bb \u2014 Farmalider\" data-secret=\"Nn3ZGBn2CS\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/farmalider.com\/wp-includes\/js\/wp-embed.min.js\n<\/script>","thumbnail_url":"https:\/\/farmalider.com\/wp-content\/uploads\/2025\/10\/ideeea_tx_anuncia_AGAcell-scaled.jpg","thumbnail_width":2560,"thumbnail_height":1067,"description":"Ideeea Therapeutics has closed a \u20ac2.3 million seed funding round to drive the development of advanced therapy medicinal products, following an open science approach and aiming for high clinical impact. This financing round will make it possible to accelerate AGAcell, a product developed by Ideeea. AGAcell is a preclinical research program that explores the intradermal [&hellip;]"}